April 13, 2021
CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 13, 2021 /PRNewswire/ -- Harbour BioMed ("HBM"; HKEX: 02142.HK), a global clinical-stage biopharmaceutical company, presents its newly discovered fully human anti-B7H7 monoclonal antibody at the American Association for...
Source URL: https://www.prnewswire.com:443/news-releases/harbour-biomed-presents-novel-antibody-for-cancer-immunotherapy-at-2021-american-association-for-cancer-research-annual-meeting-301267322.html
|
